Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1052768
Abstract: As a regulatory subunit of cyclin kinase, CKS1B promotes cancer development and is associated with poor prognosis in multiple cancer patients. However, the intrinsic role of CKS1B in pancreatic cancer remains elusive. In our research,… read more here.
Keywords: immunotherapy pancreatic; pancreatic cancer; cks1b; cks1b expression ... See more keywords